#40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.
What you'll get out of this episode:
- Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.
- Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.
- The need for diverse site participation and data inputs to improve trial accuracy and efficiency.
- The role of AI and technology in enhancing clinical trial processes.
To learn more about our guests and their companies:
Christine's LinkedIn https://www.linkedin.com/in/christinesenn/
Rohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/
Advarra LinkedIn https://www.linkedin.com/company/advarra/
Lokavant LinkedIn https://www.linkedin.com/company/lokavant/
Advarra Website https://www.advarra.com/
Lokavant Website https://www.lokavant.com/en-us/
Our sponsor for this episode is:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/